Nucleotide Metabolism: Mode of Action of Thiopurines in Leukemia
- 1 January 1995
- book chapter
- Published by Springer Nature
- Vol. 370, 195-200
- https://doi.org/10.1007/978-1-4615-2584-4_42
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblastsPublished by Elsevier ,2003
- 6-Mercaptopurine: Cytotoxicity and biochemical pharmacology in human malignant T-lymphoblastsBiochemical Pharmacology, 1993
- Cell-Kinetics and Biochemical Pharmacology of Methotrexate and 6-Mercaptopurine in Human Malignant T-LymphoblastsKlinische Padiatrie, 1992
- Methylation pharmacogenetics: Thiopurine methyltransferase as a model systemXenobiotica, 1992
- Molecular dosimetry of sister chromatid exchange induction in 9L cells treated with 6-thioguanineMutagenesis, 1991
- Characterization of the DNA damage in 6-thioguanine-treated cellsBiochemical Pharmacology, 1990
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990
- Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineagesBiochemical Pharmacology, 1988
- Variable Bioavailability of Oral MercaptopurineNew England Journal of Medicine, 1983
- Differential chromatid damage induced by 6-thioguanine in CHO cellsExperimental Cell Research, 1981